Moyamoya Syndrome as a Severe Cerebrovascular Complication of Mucopolysaccharidosis Type I: Clinical Presentation and Underlying Mechanisms
##plugins.themes.academic_pro.article.main##
Abstract
no
##plugins.themes.academic_pro.article.details##

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- Machnikowska-Sokołowska M, Myszczuk A, Wieszała E, Wieja- Błach D, Jamroz E, Paprocka J. Mucopolysaccharidosis type 1 among
- children—neuroradiological perspective based on single centre experience and literature review. Metabolites. 2023;13(2):209.
- Grant N, Taylor JM, Plummer Z, Myers K, Burrow T, Luchtman-Jones L. Cerebral revascularization in a child with mucopolysaccharidosis
- type I. Front Pediatr. 2021;9:606905.
- Olgaç A, Tümer L, Damar Ç, Hasanoğlu A, Ezgü F. Acute stroke in a patient with mucopolysaccharidosis type I with increased carotid
- intima-media thickness. EJMO. 2018;2(2):114–6.
- BraunlinEA,HarmatzPR,ScarpaM,FurlanettoB, KampmannC,Loehr JP, et al. Cardiac disease in patients with mucopolysaccharidosis:
- presentation, diagnosis, and management. J Inherit Metab Dis. 2011;34:1183–1197.
- Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, et al. Clinical outcome after 450 revascularization procedures for
- Moyamoya disease. J Neurosurg. 2009;111:927–935.